NEW YORK: Bayer held a call with investors after a raft of bad news led some of them to question whether the German group had been upfront about its prospects ahead of a US$5.75bil bond issuance, three sources familiar with the situation say.
The bad news prompted some bond investors to question whether Bayer should sweeten the terms of the deal or outright pull it, one of the sources said on Wednesday.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
